HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 172 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $607 | -99.9% | 16,421 | -14.0% | 0.05% | -32.4% |
Q2 2022 | $840,000 | +172.7% | 19,102 | +158.7% | 0.07% | +222.7% |
Q1 2021 | $308,000 | -4.6% | 7,384 | -2.3% | 0.02% | -37.1% |
Q4 2020 | $323,000 | -7.2% | 7,561 | -41.7% | 0.04% | -12.5% |
Q2 2020 | $348,000 | +54.7% | 12,979 | -2.6% | 0.04% | +300.0% |
Q2 2018 | $225,000 | -41.7% | 13,319 | -30.1% | 0.01% | -50.0% |
Q4 2017 | $386,000 | -27.2% | 19,045 | -37.6% | 0.02% | -23.1% |
Q3 2017 | $530,000 | – | 30,535 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |